Andrew R. Robbins, COO at ARRAY BIOPHARMA INC (ARRY), sold 282,874 shares at $10.72 ($3.0M) on 2017-12-18, disclosed to the SEC on 2017-12-19.
Open-market sale of $3.0M ARRY by COO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ARRY | SELL | 2017-12-19 | $3.0M | — | Filing → |